Published in early 2020, this consensus guideline has been developed in order to reexamine the role of cryopreserved amniotic membrane (CAM) in the management of cornea-involved ocular surface disease and the preparation of the ocular surface for refractive cataract surgery, all of which present continued unmet needs.

Developed from a roundtable discussion with:

Five renowned experts in anterior segment eye disease and surgery highlighted their recommendations for the use of CAM in the following indications:

• Persistent Epithelial Defect (PED)
• Corneal Ulcer/Infectious Keratitis
• Recurrent Corneal Erosion (RCE)
• Severe Dry Eye Disease (DED)

• Epithelial Basement Membrane Dystrophy (EBMD)
• Neurotrophic Keratitis (NK)
• Optimizing the ocular surface prior to refractive cataract surgery